Quantcast

Latest Antiviral drug Stories

2015-05-26 20:22:10

- New data from GIFT-I study presented at the Annual Meeting of the Japan Society of Hepatology NORTH CHICAGO, Ill., May 26, 2015 /PRNewswire/ -- AbbVie (NYSE: ABBV) presented

2015-05-11 12:31:30

MONTREAL, May 11, 2015 /PRNewswire/ - H&P Labs Inc.

2015-05-11 08:33:05

MONTREAL, May 11, 2015 /PRNewswire/ - H&P Labs Inc.

2015-04-20 08:30:02

SHELTON, Conn., April 20, 2015 /PRNewswire/ -- NanoViricides, Inc., (NYSE MKT: NNVC) (the "Company"), a nanomedicine company developing anti-viral drugs, reports dramatic improvement in clinical

2015-04-15 20:21:58

- AbbVie's investigational, interferon and ribavirin-free treatment in Japan consists of a 12-week, two direct-acting antiviral, fixed-dosed combination of paritaprevir/ritonavir with ombitasvir, dosed

2015-04-13 04:21:30

PARIS, April 13, 2015 /PRNewswire/ -- Novel mechanism of action - prevention of viral RNA exit from nucleus of infected cells - associated to unique anti-viral properties

2015-03-17 16:25:14

LONDON, March 17, 2015 /PRNewswire/ -- Report DetailsHepatitis C treatments - your guide to medical needs, R&D trends and future drug revenuesDiscover the future of treating

2015-03-12 12:29:55

MILFORD, Mass., March 12, 2015 /PRNewswire/ -- Spring Bank Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of hepatitis B and

2015-02-26 12:27:38

- Proceeds to Support Phase II Clinical Development of SB 9200 Against Hepatitis B - MILFORD, Mass., Feb.

2015-02-19 12:21:02

Phase 3 clinical trials reach required enrollment WASHINGTON, Feb.


Latest Antiviral drug Reference Libraries

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

0_d42a67c9e67a58fec0ffaab2b08808b2
2011-01-11 14:10:55

Human rhinoviruses are the most common viral ineffective agents in humans and are the cause of the common cold. The infection proliferates between 33-35 °C causing most reproduction to occur in the nose. It is a species in the genus Enterovirus of the Picornaviridae family of viruses. There are 99 recognized types of Human Rhinoviruses that are differentiated by their surface proteins. They are amongst the smallest viruses and lytic in nature. They travel via aerosols of respiratory...

More Articles (2 articles) »
Word of the Day
chickabiddy
  • A young chicken: also used as a pet name for children.
The word 'chickabiddy' may come from 'chick' plus 'biddy', a name used in calling a hen or chicken.
Related